Primary prevention strategy for cardiovascular disease in Lithuania

[1] Health Information Centre, Institute of Hygiene, Ministry of Health of The Republic of Lithuania, Causes of death 2017, Vilnius 2018. http://www.hi.lt/uploads/pdf/leidiniai/Statistikos/Mirties_priezastys/MPR_2017_isankstiniai.pdf.Search in Google Scholar

[2] WHO HFA Mortality database, 2009.Search in Google Scholar

[3] Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635–701.10.1093/eurheartj/ehs092Search in Google Scholar

[4] Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2016). The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Eur Heart J 2016;37:2315–81.10.1093/eurheartj/ehw106Search in Google Scholar

[5] Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for menscreened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–4.10.2337/diacare.16.2.434Search in Google Scholar

[6] Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and longtermcoronary heart disease mortality in different cultures:twenty-five-year follow-up of the Seven Countries Study. JAMA 1995;274:131–6.10.1001/jama.1995.03530020049031Search in Google Scholar

[7] MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease, I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765–74.10.1016/0140-6736(90)90878-9Search in Google Scholar

[8] Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827–38.10.1016/0140-6736(90)90944-ZSearch in Google Scholar

[9] Conroy RM., Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. on behalf of the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987– 1003.10.1016/S0195-668X(03)00114-3Search in Google Scholar

[10] Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.10.1001/jama.285.19.248611368702Search in Google Scholar

[11] Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESH/ESC Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Hear J 2018(39):3021–104.10.1097/HJH.000000000000196130379783Search in Google Scholar

[12] Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A. PURE Study Investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013;310:959–68.10.1001/jama.2013.18418224002282Search in Google Scholar

[13] Grabauskas V, Klumbienė J, Petkevičienė J, Petrauskienė A, Tamošiūnas A, Kriaučionienė V, et al. Lėtiniu˛ neinfekciniu˛ ligu˛ rizikos veiksniu˛ paplitimas tarp Lietuvos kaimišku˛ju˛ rajonu˛ gyventoju˛: CINDI programos tyrimas, 2007 m. Medicina (Kaunas) 2008;44(8):633–9.10.3390/medicina44080082Search in Google Scholar

[14] Lisauskienė I. Širdies ir kraujagysliu˛ sistem ˛a veikiančiu˛ vaistu˛ vartojimo ir sergamumo bei mirštamumo nuo šios sistemos ligu˛ kitimai Lietuvoje. Daktaro disertacija. Moksl. vadovė prof. J. Gulbinovič. – Vilnius, 2017, 213 p.Search in Google Scholar

[15] MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7–22.10.1016/S0140-6736(02)09327-3Search in Google Scholar

[16] Rinkūnienė E. Didelės kardiovaskulinės rizikos asmenu˛ nustatymo ir aktyvios pirminės prevencijos metodu optimizavimas. Daktaro disertacija. Mokslinė vadovė prof. Ž. Petrulionienė, moksl. konsultantas prof. A. Laucevičius. – Vilnius, 2014, 153 p.Search in Google Scholar

[17] Baltic Statistics on Medicines 2013–2015. http://www.vvkt.lt/eng/Statistics-on-consumption-of-medicinal-products-in-three-Baltic-States/956.Search in Google Scholar

[18] Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, Smith AL, Bauer DC, Newman AB, et al. Cigarette Smoking Exposure and Heart Failure Risk in Older Adults: The Health, Aging, and Body Composition Study. Am Heart J 2012;164(2):236–42.10.1016/j.ahj.2012.05.013Search in Google Scholar

[19] Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol 2018;25(13):1437–51.10.1177/2047487318780435Search in Google Scholar

[20] Barua RS, Ambrose JA. Mechanisms of Coronary Thrombosis in Cigarette Smoke Exposure. Arterioscler Thromb Vasc Biol 2013;33:1460–7.10.1161/ATVBAHA.112.300154Search in Google Scholar

[21] Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003;46:91–111.10.1016/S0033-0620(03)00087-2Search in Google Scholar

[22] Attard R, Dingli P, Doggen CJM, Cassar K, Farrugia R, Wettinger SB. The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial in- farction. Open Heart 2017;4(2):e000620.10.1136/openhrt-2017-000620557441928878948Search in Google Scholar

[23] Rea TD, Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002;137(6):494–500.10.7326/0003-4819-137-6-200209170-0000912230350Search in Google Scholar

[24] Hackshaw A., Morris JK, Boniface S, Tang JL, Milenković D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ 2018;360:j5855.10.1136/bmj.j5855578130929367388Search in Google Scholar

[25] Olin JW, Sealove BA. Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management. Mayo Clin Proc 2010;85(7):678–92.10.4065/mcp.2010.0133289472520592174Search in Google Scholar

[26] Shah RS., Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther 2010;8(7):917–32.10.1586/erc.10.56292825320602553Search in Google Scholar

[27] He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease–a meta-analysis of epidemiologic studies. N Engl J Med 1999; 340(12):920–6.10.1056/NEJM19990325340120410089185Search in Google Scholar

[28] Gardner G, Halweil B. Underfed and overfed: the global epidemic of malnutrition. Washington, DC: Worldwatch Institute, 2000.Search in Google Scholar

[29] Brimas G. Chirurginis nutukimo gydymas. Vilnius: Ciklonas, 2005, 352 p.Search in Google Scholar

[30] Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288(21):2709–16.10.1001/jama.288.21.270912460094Search in Google Scholar

[31] Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation 2009;120(16):1640–5.10.1161/CIRCULATIONAHA.109.19264419805654Search in Google Scholar

[32] Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55(13):1318–27.10.1016/j.jacc.2009.10.06120338492Search in Google Scholar

[33] Slivovskaja I. Individualios aerobinės fizinės treniruotės veiksmingumas asmenims, kuriems nustatytas metabolinis sindromas. [The effectiveness of individual aerobic training in subjects with metabolic syndrome]. Daktaro disertacija. Moksl. vadovas prof. A. Juocevičius, moksl. konsultantė dr. L. Ryliškytė. – Vlnius, 2018, 200 p.Search in Google Scholar

[34] Matheny M, McPheeters ML, Glasser A, Mercaldo N, Weaver RB, Jerome RN, et al. Systematic Review of Cardiovascular Disease Risk Assessment Tools. Evidence Syntheses/Technology Assessments, No. 85. 2011, 394 p.Search in Google Scholar

[35] Grundy SM. Metabolic Syndrome Pandemic. Arterioscler Thromb Vasc Biol 2008; 28(4):629–36.10.1161/ATVBAHA.107.15109218174459Search in Google Scholar

[36] Koller MT, Steyerberg EW, Wolbers M, Stijnen T, Bucher HC, Hunink MG, et al. Validity of the Framingham point scores in the elderly: results from the Rotterdam study. Am Heart J 2007;154(1):87–93.10.1016/j.ahj.2007.03.02217584559Search in Google Scholar

[37] Reissigova J, Zvarova J. The Framingham risk function underestimated absolute coronary heart disease risk in Czech men. Methods Inf Med 2007;46(1):43–9.10.1055/s-0038-1627830Search in Google Scholar

[38] Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The Metabolic Syndrome and Cardiovascular Risk. A Systematic Review and Meta-Analysis. Am Coll Cardiol 2010;56(14):1113–32.10.1016/j.jacc.2010.05.03420863953Search in Google Scholar

[39] Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006l;27(13):1610–9.10.1093/eurheartj/ehi73316495286Search in Google Scholar